Literature DB >> 6185837

Antigenicity, storage, and aging: physiologic autoantibodies to cell membrane and serum proteins and the senescent cell antigen.

M M Kay, K Sorensen, P Wong, P Bolton.   

Abstract

Normal human serum contains autoantibodies to a wide range of cellular and serum proteins. IgG autoantibodies to cell membrane proteins spectrin, syndein (Band 2.1), Band 3 degradation products, and the senescent cell antigen are among them. Physiologic autoantibodies to the senescent cell antigen, a approximately 62 000 dalton glycopeptide derived from Band 3, initiate removal of senescent, damaged, and stored cells in vivo. The senescent cell antigen is one of the two Band 3 degradation products (Mr approximately 66 000 and 62 000) observed in freshly prepared ghosts. Since the senescent cell antigen is observed on red cells aged in situ, data suggest that Band 3 undergoes proteolysis in situ. IgG eluted from blood stored for transfusion binds to the senescent cell antigen. The amount of IgG on red cells increases during storage suggesting accumulation of the senescent cell antigen. Autoantibodies to other cell and serum proteins are discussed as possible regulators of homeostasis. The effect of age on physiologic autoantibodies is reviewed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6185837     DOI: 10.1007/bf00242486

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  96 in total

1.  Detection of anti-idiotype reactive cells in the response to phosphorylcholine.

Authors:  H Cosenza
Journal:  Eur J Immunol       Date:  1976-02       Impact factor: 5.532

2.  Hypothesis. Auto-antibodies and immunological theories: an analytical review.

Authors:  P Grabar
Journal:  Clin Immunol Immunopathol       Date:  1975-11

3.  Anti-immunoglobulin stimulation of murine lymphocytes. V. Age-related decline in Fc receptor-mediated immunoregulation.

Authors:  D J Scribner; H L Weiner; J W Moorhead
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

4.  Role of sialic acid in survival of erythrocytes in the circulation: interaction of neuraminidase-treated and untreated erythrocytes with spleen and liver at the cellular level.

Authors:  D Aminoff; W F Bruegge; W C Bell; K Sarpolis; R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

5.  Purification of two spectrin-binding proteins: biochemical and electron microscopic evidence for site-specific reassociation between spectrin and bands 2.1 and 4.1.

Authors:  J M Tyler; W R Hargreaves; D Branton
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

6.  Glycoproteins: isolation from cellmembranes with lithium diiodosalicylate.

Authors:  V T Marchesi; E P Andrews
Journal:  Science       Date:  1971-12-17       Impact factor: 47.728

7.  High proportion of Ig-producing cells making autoantibody in normal mice.

Authors:  E J Steele; A J Cunningham
Journal:  Nature       Date:  1978-08-03       Impact factor: 49.962

8.  Human sperm antigens and antisperm antibodies I. Studies on vasectomy patients.

Authors:  K S Tung
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

9.  Feedback regulation of immune responses by immune complexes; possible involvement of a suppressive lymphokine by FcR gamma-bearing B cell.

Authors:  M Miyama-Inaba; T Suzuki; Y H Paku; T Masuda
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

10.  Autoregulation of an antibody response via network-induced auto-anti-idiotype.

Authors:  J C Brown; L S Rodkey
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

View more
  12 in total

1.  A monoclonal antibody monitoring band 3 modifications in human red blood cells.

Authors:  A Giuliani; S Marini; L Ferroni; P Caprari; S G Condò; M T Ramacci; B Giardina
Journal:  Mol Cell Biochem       Date:  1992-11-04       Impact factor: 3.396

2.  Alteration in membrane protein band 3 associated with accelerated erythrocyte aging.

Authors:  M M Kay; N Flowers; J Goodman; G Bosman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

3.  Functional topography of band 3: specific structural alteration linked to functional aberrations in human erythrocytes.

Authors:  M M Kay; G J Bosman; C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

4.  Definition of a physiologic aging autoantigen by using synthetic peptides of membrane protein band 3: localization of the active antigenic sites.

Authors:  M M Kay; J J Marchalonis; J Hughes; K Watanabe; S F Schluter
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

5.  Heart-specific autoantibodies can be eluted from the hearts of Coxsackievirus B3-infected mice.

Authors:  D A Neumann; J R Lane; A LaFond-Walker; G S Allen; S M Wulff; A Herskowitz; N R Rose
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

6.  Co-clustering of denatured hemoglobin with band 3: its role in binding of autoantibodies against band 3 to abnormal and aged erythrocytes.

Authors:  K Schlüter; D Drenckhahn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

7.  Heinz bodies induce clustering of band 3, glycophorin, and ankyrin in sickle cell erythrocytes.

Authors:  S M Waugh; B M Willardson; R Kannan; R J Labotka; P S Low
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

8.  Localization of senescent cell antigen on band 3.

Authors:  M M Kay
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

9.  Polypeptides immunologically related to band 3 are present in nucleated somatic cells.

Authors:  M M Kay; C M Tracey; J R Goodman; J C Cone; P S Bassel
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

10.  Molecular mapping of human band 3 aging antigenic sites and active amino acids using synthetic peptides.

Authors:  M M Kay
Journal:  J Protein Chem       Date:  1992-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.